FREE SHIPPING ON ORDER OVER $300 - PURE QUALITY - TESTED IN USA

CBL-514 – 20mg

$199.00

Choose Your Bundle

Quantity

Description

Chemical Composition

  • CAS Number: 501-36-0
  • Molecular Formula: C₁₄H₁₂O₃
  • Molecular Weight: 228.25 g/mol

Curcumin

  • CAS Number: 458-37-7
  • Molecular Formula: C₂₁H₂₀O₆
  • Molecular Weight: 368.38 g/mol

Product Content

  • CBL-514 (Small-Molecule Lipolytic Agent): 20mg
  • Form: Lyophilized powder

Description

Product Content

• Product identifier: CBL-514
• Labeled content: 20 mg per vial
• Form: Lyophilized powder

Description

CBL-514 is supplied as a laboratory research material with a labeled content of 20 mg per vial. It is intended exclusively for controlled laboratory investigations. Refer to the batch-specific laboratory documentation for verified identity, composition, and analytical results.

For laboratory and research use only. Not for human consumption. Not a drug, food or cosmetic.

Storage and Handling

  • Store at -20°C prior to reconstitution

  • After reconstitution, store at 2–8°C

  • Avoid repeated freeze-thaw cycles

  • Protect from light and moisture

  • Use sterile laboratory handling procedures

Product Specifications

  • High analytical purity (≥99% HPLC Verified)

  • Research-grade standard

  • Appearance: Yellow to off-white lyophilized powder (coloration due to active curcumin content)

  • Batch / Lot Number: CEL-0926-47

Compliance Notice

FOR RESEARCH USE ONLY.

Not for human or veterinary use.

Not evaluated by the FDA.

This product is intended strictly for laboratory and scientific research applications.

Get 15% Off Your First Research Order

Subscribe to receive your exclusive welcome discount and updates on new research compounds and product releases.

Are You 21 Years of Age or Older?

This website contains information and products intended for laboratory research purposes only. Access is restricted to individuals who are 21 years of age or older.

By entering this site, you confirm that you meet the age requirement and agree to our Terms of Use.